Ionis, AstraZeneca Rare Disease Drug Wins FDA Approval

Ionis Pharmaceuticals and AstraZeneca’s Wainua (eplontersen) has received FDA approval, according to a post on the US agency’s website for approved drugs. Shares of IONS are up 3.4% in light postmarket trading.

• The prescription label wasn’t immediately available
• The companies had sought approval for the drug as a treatment for people with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN)
• A decision by the Food and Drug Administration had been expected by Dec. 22

To contact the reporter on this story:
Jeremy R. Cooke in Mount Pleasant, SC at jcooke8@bloomberg.net

To contact the editors responsible for this story:
Matt Turner at mturner107@bloomberg.net

Boris Korby

© ...